LPTX Leap Tx: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Leap Therapeutics Inc (LPTX)

The development of antibodies for the gastrointestinal tract is currently in the R&D stage, which is blocking operational leverage for Leap Therapeutics, Inc. (LPTX). The company's EV/Sales valuation on this GURU.Markets chart reflects this trend, where determines the latest valuation metric. The LPTX business is entirely non-cyclical and resilient to macro shocks, while ownership of unique rights to niche drugs guarantees strong pricing power.

Nilai perusahaan marang pendapatan: Leap Tx (LPTX) kanggo 04.07.2022 - 20.11.2026

Leap Tx - rincian analitis lan metrik utama (LPTX)

- rega saham lan konsensus proyeksi valuasi:
- informasi babagan dhuwit lan arus kas:
Analisis wiwitan perusahaan:Leap Therapeutics Inc LPTX
Sampel barang Leap Therapeutics Inc

To minimize investment risks, it is necessary to assess the business's actual margin of safety by excluding the impact of debt load on capitalization. By analyzing the EV/Sales history, an investor can see the ratio of the company's total enterprise value to revenue, which helps determine the fairness of the market price relative to the revenues of Leap Therapeutics, Inc. (LPTX) amid effective liquidity management and management's focus on developing its oncology portfolio.

Analisis pesaing Leap Therapeutics, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIMN|Multiplikator EV/Sales Lava Tx (LVTX)|Multiplikator EV/Sales NXTC (NextCure Corporation)|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP